The study by Mann et al. investigates the effects of norepinephrine on adult mammalian cardiomyocytes, revealing that adrenergic stimulation leads to cyclic AMP (cAMP)-mediated calcium overload, resulting in decreased synthetic activity and cell viability. The research used isolated cultured cardiomyocytes to examine the direct effects of norepinephrine on cardiomyocyte biology. Norepinephrine exposure caused a concentration-dependent decrease in cardiomyocyte viability, as evidenced by reduced viable rod-shaped cells and increased creatine kinase release. β-adrenoceptor blockade significantly attenuated this toxicity, while α-adrenoceptor stimulation had a lesser effect. Norepinephrine also reduced the incorporation of [³H]phenylalanine and [³H]uridine into cytoplasmic protein and nuclear RNA, respectively, with β-adrenoceptor blockade and selective β-adrenoceptor stimulation mimicking these effects. The study suggests that norepinephrine-induced toxicity is due to cAMP-mediated calcium overload, as pharmacological strategies that increase intracellular cAMP reduced cell viability, and calcium influx through verapamil-sensitive channels was necessary for cell death. Time-course studies showed that norepinephrine caused a rapid fourfold increase in intracellular cAMP, followed by a 3.2-fold increase in intracellular calcium. The findings indicate that adrenergic stimulation leads to cAMP-mediated calcium overload, resulting in decreased synthetic activity and cell viability. The study also highlights the importance of understanding adrenergic effects on cardiomyocytes, as excessive adrenergic stimulation can exacerbate cardiovascular disease. The research used isolated cardiomyocytes to examine the direct effects of norepinephrine, and the results support the view that catecholamine cardiotoxicity is due to cAMP-mediated calcium overload of the cardiomyte. The study provides insights into the mechanisms of adrenergic cardiotoxicity and has implications for understanding and treating cardiovascular diseases.The study by Mann et al. investigates the effects of norepinephrine on adult mammalian cardiomyocytes, revealing that adrenergic stimulation leads to cyclic AMP (cAMP)-mediated calcium overload, resulting in decreased synthetic activity and cell viability. The research used isolated cultured cardiomyocytes to examine the direct effects of norepinephrine on cardiomyocyte biology. Norepinephrine exposure caused a concentration-dependent decrease in cardiomyocyte viability, as evidenced by reduced viable rod-shaped cells and increased creatine kinase release. β-adrenoceptor blockade significantly attenuated this toxicity, while α-adrenoceptor stimulation had a lesser effect. Norepinephrine also reduced the incorporation of [³H]phenylalanine and [³H]uridine into cytoplasmic protein and nuclear RNA, respectively, with β-adrenoceptor blockade and selective β-adrenoceptor stimulation mimicking these effects. The study suggests that norepinephrine-induced toxicity is due to cAMP-mediated calcium overload, as pharmacological strategies that increase intracellular cAMP reduced cell viability, and calcium influx through verapamil-sensitive channels was necessary for cell death. Time-course studies showed that norepinephrine caused a rapid fourfold increase in intracellular cAMP, followed by a 3.2-fold increase in intracellular calcium. The findings indicate that adrenergic stimulation leads to cAMP-mediated calcium overload, resulting in decreased synthetic activity and cell viability. The study also highlights the importance of understanding adrenergic effects on cardiomyocytes, as excessive adrenergic stimulation can exacerbate cardiovascular disease. The research used isolated cardiomyocytes to examine the direct effects of norepinephrine, and the results support the view that catecholamine cardiotoxicity is due to cAMP-mediated calcium overload of the cardiomyte. The study provides insights into the mechanisms of adrenergic cardiotoxicity and has implications for understanding and treating cardiovascular diseases.